Acorah Software Products - Accounts Production 19.2.450 false true false true No description of principal activity 29 May 2025 31 May 2026 31 May 2026 16481916 Professor Frances Flinter Professor Alastair Watson iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 16481916 2025-05-28 16481916 2026-05-31 16481916 2025-05-29 2026-05-31 16481916 frs-core:CurrentFinancialInstruments 2026-05-31 16481916 frs-bus:PrivateLimitedCompanyLtd 2025-05-29 2026-05-31 16481916 frs-bus:FilletedAccounts 2025-05-29 2026-05-31 16481916 frs-bus:Micro-entities 2025-05-29 2026-05-31 16481916 frs-bus:AuditExempt-NoAccountantsReport 2025-05-29 2026-05-31 16481916 frs-bus:Director1 2025-05-29 2026-05-31 16481916 frs-bus:Director2 2025-05-29 2026-05-31
Registered number: 16481916
European Doctors Orchestra Administration Ltd
Unaudited Financial Statements
For The Year Ended 31 May 2026
NFMS Enterprises Ltd
Balance Sheet
Registered number: 16481916
2026
£
Current assets 18,344
Creditors: Amounts Falling Due Within One Year (16,054 )
NET CURRENT ASSETS 2,290
TOTAL ASSETS LESS CURRENT LIABILITIES 2,290
Accruals and deferred income (2,288 )
NET ASSETS 2
CAPITAL AND RESERVES 2

Notes

1. General Information
European Doctors Orchestra Administration Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 16481916 . The registered office is 11 Littlewood, Drayton, Norwich, NR8 6FB.
2. Average Number of Employees
Average number of employees, including directors, during the year was: NIL
-
For the year ending 31 May 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
On behalf of the board
Professor Alastair Watson
Director
12/06/2026